Not finding it? Sign in to also search OpenAlex live.
-
Ensemble-based satellite-derived carbon dioxide and methane column-averaged dry-air mole fraction data sets (2003–2018) for carbon and climate applications2020 Atmospheric measurement techniques article Environmental Science Atmospheric and Environmental Gas Dynamics Open access
Maximilian Reuter, Michael Buchwitz, Oliver Schneising, Stefan Noël, H. Bovensmann, Hartmut Boesch, +34 more
44citations -
Should LC-MS/MS Be the Reference Measurement Procedure to Determine Protein Concentrations in Human Samples?2020 Clinical Chemistry article Medicine Clinical Laboratory Practices and Quality Control Open access
Andrew N. Hoofnagle, Christa M. Cobbaert, Vincent Delatour, Neil L. Kelleher, Mark S. Lowenthal, Christopher M. Shuford
27citations -
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation2023 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
Caroline Duineveld, Romy N. Bouwmeester, Kioa Lente Wijnsma, Fréderike J. Bemelman, Joost W van der Heijden, Stefan P. Berger, +14 more
21citations -
#425 Felzartamab (anti-CD38) in patients with IgA Nephropathy—interim results from the IGNAZ study2024 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies cited by 1 patent
Jürgen Floege, Richard A. Lafayette, Jonathan Barratt, Brian S. Schwartz, Paul T. Manser, Uptal D. Patel, +6 more
13citations -
Triple junction benchmark for multiphase-field models combining capillary and bulk driving forces2024 Modelling and Simulation in Materials Science and Engineering article Materials Science Solidification and crystal growth phenomena Open access
Paul Wilhelm Hoffrogge, Simon Daubner, Daniel Schneider, Britta Nestler, Janin Eiken
11citations -
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial
Anna Paula Brandt, Christoph Schultheiß, Konrad Friedrich Klinghammer, Philippe Schafhausen, Chia‐Jung Busch, Markus Blaurock, +8 more
11citations -
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
Jayesh Desai, Andrew J. Wagner, Irene Carrasco García, Marilena Cesari, Chia‐Chi Lin, Zsuzsanna Pápai, +11 more
10citations